Histogen DPO Ratio 2011-2026 | HSTO

Annual DPO Ratio Histogen

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	203	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
203	203	203

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Aquestive Therapeutics AQST	395	$ 4.12	-0.36 %	$ 441 M	USA
Arcutis Biotherapeutics ARQT	133	$ 23.65	0.08 %	$ 3.01 B	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
BioXcel Therapeutics BTAI	34.2 K	$ 1.16	-2.12 %	$ 14.2 M	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Catalyst Biosciences CBIO	7.82	$ 19.48	0.39 %	$ 1.74 B	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Codexis CDXS	85.8	$ 1.95	6.87 %	$ 170 M	USA
Cerus Corporation CERS	242	$ 1.91	2.69 %	$ 364 M	USA
Coherus BioSciences CHRS	507	$ 1.72	-0.87 %	$ 201 M	USA
CollPlant Biotechnologies Ltd. CLGN	72.6	$ 0.46	-13.02 %	$ 5.27 M	Israel
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
Catalyst Pharmaceuticals CPRX	58.1	$ 24.95	1.05 %	$ 3.05 B	USA
Celldex Therapeutics CLDX	4.06 K	$ 31.33	0.85 %	$ 2.08 B	USA
Cardiff Oncology CRDF	406	$ 1.6	1.27 %	$ 107 M	USA